Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy.
作者信息
Forlenza Gregory P
机构信息
University of Colorado Denver, Barbara Davis Center, Pediatric Endocrinology, Aurora, Colorado.
出版信息
Diabetes Technol Ther. 2019 Jun;21(S2):S24-S28. doi: 10.1089/dia.2019.0077.
Abstract
摘要
相似文献
1
Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy.利用人工智能改善每日多次注射治疗患者的糖尿病治疗效果。
Diabetes Technol Ther. 2019 Jun;21(S2):S24-S28. doi: 10.1089/dia.2019.0077.
2
Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.1型糖尿病患者持续皮下胰岛素输注与每日多次注射的比较：一项系统评价和荟萃分析。
Endocrine. 2017 Jan;55(1):77-84. doi: 10.1007/s12020-016-1039-x. Epub 2016 Aug 1.
3
Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.西班牙1型糖尿病患者发生严重复发性低血糖事件时持续皮下胰岛素输注治疗的预算影响
Endocrinol Diabetes Nutr. 2017 Aug-Sep;64(7):377-383. doi: 10.1016/j.endinu.2017.04.006. Epub 2017 Jun 7.
4
[Taking the peak out of blood pressure. Diabetics can also live spontaneously].[降低血压峰值。糖尿病患者也能自然生活]
MMW Fortschr Med. 1999 Dec 9;141(49-50):66-7.
5
Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.持续皮下胰岛素输注与多次每日注射治疗1型糖尿病女性的妊娠结局及胰岛素需求：队列研究
Diabetes Technol Ther. 2017 May;19(5):280-287. doi: 10.1089/dia.2016.0412. Epub 2017 Mar 10.
6
Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK: Response to Roze et al.英国持续皮下胰岛素输注与多次每日注射治疗1型糖尿病的卫生经济学比较：对罗泽等人的回应
Diabet Med. 2006 Jun;23(6):709; author reply 708. doi: 10.1111/j.1464-5491.2006.01853.x.
7
Tailoring intensified insulin therapy in children.儿童强化胰岛素治疗的个体化
Pediatr Diabetes. 2009 Aug;10(5):295-7. doi: 10.1111/j.1399-5448.2009.00561.x.
8
The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.皮下胰岛素输注与多次胰岛素注射对 1 型糖尿病青年患者血糖变异性的影响：观察性 METRO 研究的 2 年随访结果。
Diabetes Technol Ther. 2018 Feb;20(2):117-126. doi: 10.1089/dia.2017.0334. Epub 2018 Jan 5.
9
[Clinical aspects of Insulin Lispro (LY275585)].赖脯胰岛素（LY275585）的临床方面
Nihon Rinsho. 1997 Nov;55 Suppl:298-305.
10
Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.基础胰岛素剂量与总胰岛素剂量的比例与儿童 1 型糖尿病的代谢控制、体重指数和治疗方式有关——来自国际 SWEET 登记处的横断面研究数据。
J Pediatr. 2019 Dec;215:216-222.e1. doi: 10.1016/j.jpeds.2019.06.002. Epub 2019 Jul 22.
引用本文的文献
1
Smart Healthcare: The Role of Digital Health in Modern Medicine.智能医疗保健：数字健康在现代医学中的作用。
Health Care Sci. 2025 Jun 1;4(3):179-187. doi: 10.1002/hcs2.70019. eCollection 2025 Jun.
2
Machine learning and deep learning in diabetology: revolutionizing diabetes care.糖尿病学中的机器学习与深度学习：变革糖尿病护理
Front Clin Diabetes Healthc. 2025 May 27;6:1547689. doi: 10.3389/fcdhc.2025.1547689. eCollection 2025.
3
A Multidisciplinary Approach of Type 1 Diabetes: The Intersection of Technology, Immunotherapy, and Personalized Medicine.1型糖尿病的多学科治疗方法：技术、免疫疗法与个性化医疗的交叉融合
J Clin Med. 2025 Mar 21;14(7):2144. doi: 10.3390/jcm14072144.
4
Need for an Artificial Intelligence-based Diabetes Care Management System in India and the United States.印度和美国对基于人工智能的糖尿病护理管理系统的需求。
Health Serv Res Manag Epidemiol. 2024 Aug 28;11:23333928241275292. doi: 10.1177/23333928241275292. eCollection 2024 Jan-Dec.
5
Regulatory Frameworks for AI-Enabled Medical Device Software in China: Comparative Analysis and Review of Implications for Global Manufacturer.中国人工智能驱动的医疗设备软件监管框架：对全球制造商的比较分析及影响综述
JMIR AI. 2024 Jul 29;3:e46871. doi: 10.2196/46871.
6
Medical-informed machine learning: integrating prior knowledge into medical decision systems.医学信息机器学习：将先验知识集成到医学决策系统中。
BMC Med Inform Decis Mak. 2024 Jun 28;24(Suppl 4):186. doi: 10.1186/s12911-024-02582-4.
7
Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire).评估 1 型糖尿病成年患者对胰岛素泵治疗的态度：胰岛素泵态度问卷（IT-IPA 问卷）的意大利用户验证。
Acta Diabetol. 2023 May;60(5):687-695. doi: 10.1007/s00592-023-02046-7. Epub 2023 Feb 20.
8
Artificial Intelligence: Review of Current and Future Applications in Medicine.人工智能：医学领域当前及未来应用综述
Fed Pract. 2021 Nov;38(11):527-538. doi: 10.12788/fp.0174.
9
Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study.新型糖尿病支持系统对接受多次每日注射治疗的 1 型糖尿病患者队列的影响：一项多中心随机研究。
Diabetes Care. 2022 Jan 1;45(1):186-193. doi: 10.2337/dc21-0838.
10
The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database.基于人工智能且获美国食品药品监督管理局批准的医疗设备及算法的现状：一个在线数据库。
NPJ Digit Med. 2020 Sep 11;3:118. doi: 10.1038/s41746-020-00324-0. eCollection 2020.
本文引用的文献
1
State of Type 1 Diabetes Care in the United States in 2016-2018 from T1D Exchange Registry Data.2016 - 2018年美国1型糖尿病护理状况：来自T1D交换登记数据
Diabetes Technol Ther. 2019 Feb;21(2):62-65. doi: 10.1089/dia.2019.0008.
2
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.2016-2018 年 T1D 交换计划中 1 型糖尿病管理状况和结果。
Diabetes Technol Ther. 2019 Feb;21(2):66-72. doi: 10.1089/dia.2018.0384. Epub 2019 Jan 18.
3
Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.MiniMed 670G 系统在 7-13 岁 1 型糖尿病儿童中的安全性评估。
Diabetes Technol Ther. 2019 Jan;21(1):11-19. doi: 10.1089/dia.2018.0264. Epub 2018 Dec 26.
4
7. Diabetes Technology: .7. 糖尿病技术： 。
Diabetes Care. 2019 Jan;42(Suppl 1):S71-S80. doi: 10.2337/dc19-S007.
5
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.在诊室内评估 1 型糖尿病儿童使用 MiniMed 670G 系统的“低血糖暂停”功能。
Diabetes Technol Ther. 2018 Nov;20(11):731-737. doi: 10.1089/dia.2018.0209. Epub 2018 Oct 6.
6
Transforming Diabetes Care Through Artificial Intelligence: The Future Is Here.通过人工智能改变糖尿病护理：未来已来。
Popul Health Manag. 2019 Jun;22(3):229-242. doi: 10.1089/pop.2018.0129. Epub 2018 Oct 2.
7
Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch.美敦力 670G 系统商业上市后 3 个月真实世界血糖数据的回顾性分析。
Diabetes Technol Ther. 2018 Oct;20(10):689-692. doi: 10.1089/dia.2018.0202. Epub 2018 Aug 30.
8
Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.预测性低葡萄糖暂停在家庭内随机交叉研究中降低 1 型糖尿病成人、青少年和儿童的低血糖：PROLOG 试验结果。
Diabetes Care. 2018 Oct;41(10):2155-2161. doi: 10.2337/dc18-0771. Epub 2018 Aug 8.
9
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies.《国际儿童青少年糖尿病研究学会（ISPAD）2018年临床实践共识指南：糖尿病技术》
Pediatr Diabetes. 2018 Oct;19 Suppl 27:302-325. doi: 10.1111/pedi.12731.
10
Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.连续血糖监测和胰岛素智能咨询系统，结合胰岛素自动调整和给药，可降低 1 型糖尿病患者的血糖变异性。
Diabetes Technol Ther. 2018 Aug;20(8):531-540. doi: 10.1089/dia.2018.0079. Epub 2018 Jul 6.
Zotero 插件